Experimental approaches to reduce PPARGC1A levels partially recapitulates the BCAA gene set profile identified in skeletal muscle from individuals with type 2 diabetes, without impacting circulating and intramuscular BCAA levels. Here, PPARGC1A is linked to type 2 diabetes mellitus.